Esperion Therapeutics, Inc. (ESPR)
2.695
+0.26
(+10.45%)
USD |
NASDAQ |
Mar 16, 16:00
2.695
0.00 (0.00%)
After-Hours: 18:24
Esperion Therapeutics EPS Diluted (Quarterly) : 0.2173 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.778 |
| Harrow, Inc. | 0.178 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| AnaptysBio, Inc. | 1.583 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 61.83M |
| Revenue (Quarterly) | 168.45M |
| Total Expenses (Quarterly) | 106.62M |
| Enterprise Value | 963.46M |
| Gross Profit Margin (Quarterly) | 83.46% |
| Profit Margin (Quarterly) | 36.71% |
| Earnings Yield | -7.77% |
| Operating Earnings Yield | 10.18% |
| Normalized Earnings Yield | -7.774 |